24/7 Patient Assistance: 760-405-8205

Charles M. Dollbaum, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Charles Dollbaum graduated the medical school from the David Geffen School of Medicine and completed his residency program at the Cedars-Sinai Medical Center. A fellowship followed at the UCSF soon after that. Dr. Dollbaum is specialized in oncology and board certified in internal medicine and medical oncology. He has been in practice for more than 20 years and is affiliated with the San Francisco General Hospital. During his career, he has also published several writings of medical interest in collaboration with other doctors.



  • Education & Training

    dept_icon

    David Geffen School of Medicine at UCLA

    Medical School

    dept_icon

    Cedars-Sinai Medical Center

    Residency

    dept_icon

    UCSF

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    San Francisco General Hospital

    Languages: English/Spanish

    (415) 206-8000

    1001 Potrero Ave

    San Francisco, California 94110

    Read More

    UCSF Medical Center

    Languages: English/Spanish

    (415) 353-1037

    505 Parnassus Ave

    San Francisco, California 94143

    Read More
  • Publications & Memberships

    Dr. Charles M. Dollbaum has contributed to 3 publications.

    Validation of salivary testosterone as a screening test for male hypogonadism.

    Morley, J.E., Perry, H.M., Patrick, P., Dollbaum, C.M., Kells, J.M.; Aging Male. 2006 Sep.

    See more >>

    Molecular lesions involved in the progression of a human breast cancer.

    Liu, E., Dollbaum, C., Scott, G., Rochlitz, C., Benz, C., Smith, H. S.; Oncogene. 1988 Sep.

    See more >>

    Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicin.

    Dollbaum, C., Creasey, A. A., Dairkee, S. H., Hiller, A. J., Rudolph, A. R., Lin, L., Vitt, C., Smith, H. S.; Proc Natl Acad Sci U S A. 1988 Jul.

    See more >>